PCI Biotech Holding ASA (LON:0JGL)

PCI Biotech Holding ASA Statistics

Total Valuation

LON:0JGL has a market cap or net worth of GBP 658,159. The enterprise value is -368,609.

Market Cap	658,159
Enterprise Value	-368,609

Important Dates

The next estimated earnings date is Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	37.33M
Shares Outstanding	n/a
Shares Change (YoY)	+1.07%
Shares Change (QoQ)	-0.41%
Owned by Insiders (%)	10.69%
Owned by Institutions (%)	22.93%
Float	27.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.95
PB Ratio	0.73
P/TBV Ratio	0.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.25
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.31

Financial Position

The company has a current ratio of 2.94, with a Debt / Equity ratio of 0.02.

Current Ratio	2.94
Quick Ratio	2.94
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-206.02

Financial Efficiency

Return on equity (ROE) is -92.47% and return on invested capital (ROIC) is -59.86%.

Return on Equity (ROE)	-92.47%
Return on Assets (ROA)	-48.34%
Return on Invested Capital (ROIC)	-59.86%
Return on Capital Employed (ROCE)	-172.86%
Weighted Average Cost of Capital (WACC)	11.56%
Revenue Per Employee	67,649
Profits Per Employee	-296,368
Employee Count	5
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.73% in the last 52 weeks. The beta is 1.23, so LON:0JGL's price volatility has been higher than the market average.

Beta (5Y)	1.23
52-Week Price Change	-80.73%
50-Day Moving Average	0.27
200-Day Moving Average	2.65
Relative Strength Index (RSI)	49.97
Average Volume (20 Days)	68,049

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0JGL had revenue of GBP 338,244 and -1.48 million in losses. Loss per share was -0.04.

Revenue	338,244
Gross Profit	338,244
Operating Income	-1.56M
Pretax Income	-1.48M
Net Income	-1.48M
EBITDA	-1.53M
EBIT	-1.56M
Loss Per Share	-0.04

Balance Sheet

The company has 982,481 in cash and 20,347 in debt, with a net cash position of 962,134.

Cash & Cash Equivalents	982,481
Total Debt	20,347
Net Cash	962,134
Net Cash Per Share	n/a
Equity (Book Value)	902,970
Book Value Per Share	0.02
Working Capital	841,353

Cash Flow

In the last 12 months, operating cash flow was -1.14 million and capital expenditures -45,527, giving a free cash flow of -1.19 million.

Operating Cash Flow	-1.14M
Capital Expenditures	-45,527
Free Cash Flow	-1.19M
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-461.45%
Pretax Margin	-438.10%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0JGL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.07%
Shareholder Yield	-1.07%
Earnings Yield	-225.15%
FCF Yield	-180.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1